{"id":"https://openalex.org/W2734442974","doi":"https://doi.org/10.1007/s13311-017-0557-4","title":"Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis","display_name":"Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis","publication_year":2017,"publication_date":"2017-07-10","ids":{"openalex":"https://openalex.org/W2734442974","doi":"https://doi.org/10.1007/s13311-017-0557-4","mag":"2734442974","pmid":"https://pubmed.ncbi.nlm.nih.gov/28695471","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5722762"},"language":"en","primary_location":{"id":"doi:10.1007/s13311-017-0557-4","doi":"https://doi.org/10.1007/s13311-017-0557-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13311-017-0557-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13311-017-0557-4.pdf","source":{"id":"https://openalex.org/S75519821","display_name":"Neurotherapeutics","issn_l":"1878-7479","issn":["1878-7479","1933-7213"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurotherapeutics","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://link.springer.com/content/pdf/10.1007/s13311-017-0557-4.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040364341","display_name":"Jeffrey Marc Gelfand","orcid":"https://orcid.org/0000-0002-5121-3319","observed_orcids":["https://orcid.org/0000-0002-5121-3319"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey M. Gelfand","raw_affiliation_strings":["Multiple Sclerosis Center, Weill Institute for Neurosciences, University of California, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Multiple Sclerosis Center, Weill Institute for Neurosciences, University of California, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020903163","display_name":"Bruce Cree","orcid":"https://orcid.org/0000-0001-7689-2533","observed_orcids":["https://orcid.org/0000-0001-7689-2533"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bruce A.C. Cree","raw_affiliation_strings":["Multiple Sclerosis Center, Weill Institute for Neurosciences, University of California, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Multiple Sclerosis Center, Weill Institute for Neurosciences, University of California, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5104805489","display_name":"Stephen L. Hauser","orcid":"https://orcid.org/0000-0002-4932-4001","observed_orcids":["https://orcid.org/0000-0002-4932-4001"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stephen L. Hauser","raw_affiliation_strings":["Multiple Sclerosis Center, Weill Institute for Neurosciences, University of California, San Francisco, CA, USA. stephen.hauser@ucsf.edu","Multiple Sclerosis Center, Weill Institute for Neurosciences, University of California, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Multiple Sclerosis Center, Weill Institute for Neurosciences, University of California, San Francisco, CA, USA. stephen.hauser@ucsf.edu","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Multiple Sclerosis Center, Weill Institute for Neurosciences, University of California, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5104805489"],"corresponding_institution_ids":["https://openalex.org/I180670191"],"apc_list":{"value":3900,"currency":"USD","value_usd":3900},"apc_paid":null,"fwci":2.3921,"has_fulltext":true,"cited_by_count":207,"citation_normalized_percentile":{"value":0.9219935,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"14","issue":"4","first_page":"835","last_page":"841"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11827","display_name":"Polyomavirus and related diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ocrelizumab","display_name":"ocrelizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.902999997138977},{"id":"https://openalex.org/keywords/b-cell-depletion","display_name":"B-cell depletion","score":0.9240000247955322},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9710000157356262},{"id":"https://openalex.org/keywords/relapsing-remitting-multiple-sclerosis","display_name":"relapsing-remitting multiple sclerosis","score":0.9879999756813049},{"id":"https://openalex.org/keywords/primary-progressive-multiple-sclerosis","display_name":"primary progressive multiple sclerosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/disability-progression","display_name":"disability progression","score":0.8109999895095825},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9819999933242798},{"id":"https://openalex.org/keywords/ofatumumab","display_name":"ofatumumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/infusion-related-reactions","display_name":"infusion reactions","score":0.9459999799728394},{"id":"https://openalex.org/keywords/infection","display_name":"infection","score":0.7900000214576721},{"id":"https://openalex.org/keywords/cancer-risk","display_name":"cancer risk","score":0.8209999799728394},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6700000166893005}],"concepts":[{"id":"https://openalex.org/C2778843634","wikidata":"https://www.wikidata.org/wiki/Q2013780","display_name":"Ocrelizumab","level":4,"score":0.9960250854492188},{"id":"https://openalex.org/C2778714382","wikidata":"https://www.wikidata.org/wiki/Q410656","display_name":"Ofatumumab","level":4,"score":0.8780626058578491},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8774222135543823},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.7049726247787476},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.6878138780593872},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.6802977323532104},{"id":"https://openalex.org/C2779171977","wikidata":"https://www.wikidata.org/wiki/Q3151081","display_name":"Filgrastim","level":4,"score":0.5250349044799805},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.46450042724609375},{"id":"https://openalex.org/C2776036978","wikidata":"https://www.wikidata.org/wiki/Q425137","display_name":"Fingolimod","level":3,"score":0.4542423486709595},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.4111127257347107},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37196505069732666},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.36622354388237},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.339575856924057},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.17822745442390442},{"id":"https://openalex.org/C2777767877","wikidata":"https://www.wikidata.org/wiki/Q419327","display_name":"Granulocyte colony-stimulating factor","level":3,"score":0.17120417952537537},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.14581361413002014}],"mesh":[{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018951","descriptor_name":"Antigens, CD20","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1007/s13311-017-0557-4","doi":"https://doi.org/10.1007/s13311-017-0557-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13311-017-0557-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13311-017-0557-4.pdf","source":{"id":"https://openalex.org/S75519821","display_name":"Neurotherapeutics","issn_l":"1878-7479","issn":["1878-7479","1933-7213"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurotherapeutics","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5109466","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5722762","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5722762","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5722762","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurotherapeutics","raw_type":"Text"},{"id":"pmid:28695471","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28695471","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt6z9964v0","doi":null,"is_oa":false,"landing_page_url":"https://escholarship.org/uc/item/6z9964v0","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Neurotherapeutics, vol 14, iss 4","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1007/s13311-017-0557-4","doi":"https://doi.org/10.1007/s13311-017-0557-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13311-017-0557-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13311-017-0557-4.pdf","source":{"id":"https://openalex.org/S75519821","display_name":"Neurotherapeutics","issn_l":"1878-7479","issn":["1878-7479","1933-7213"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurotherapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6133376561","display_name":"Gene linkage study of multiple sclerosis sibling pairs","funder_award_id":"R01NS026799","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G8766533054","display_name":"A Haplotype Map for Multiple Sclerosis","funder_award_id":"R01NS049477","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"}],"funders":[{"id":"https://openalex.org/F4320306161","display_name":"National Multiple Sclerosis Society","ror":"https://ror.org/03019wv17"},{"id":"https://openalex.org/F4320306180","display_name":"Conrad N. Hilton Foundation","ror":"https://ror.org/05g9snv96"},{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2734442974.pdf","grobid_xml":"https://content.openalex.org/works/W2734442974.grobid-xml"},"referenced_works_count":49,"referenced_works":["https://openalex.org/W927234285","https://openalex.org/W1484629663","https://openalex.org/W1772431248","https://openalex.org/W1816536644","https://openalex.org/W1945808878","https://openalex.org/W1966849321","https://openalex.org/W1968634262","https://openalex.org/W1975104912","https://openalex.org/W1981621288","https://openalex.org/W1995353727","https://openalex.org/W2011854432","https://openalex.org/W2019181818","https://openalex.org/W2020206181","https://openalex.org/W2029012161","https://openalex.org/W2040547343","https://openalex.org/W2042725832","https://openalex.org/W2048324178","https://openalex.org/W2061964547","https://openalex.org/W2083565083","https://openalex.org/W2086080135","https://openalex.org/W2097781344","https://openalex.org/W2105167551","https://openalex.org/W2106804464","https://openalex.org/W2107008240","https://openalex.org/W2114360739","https://openalex.org/W2115351802","https://openalex.org/W2122545833","https://openalex.org/W2123021165","https://openalex.org/W2126336004","https://openalex.org/W2126778627","https://openalex.org/W2129134090","https://openalex.org/W2130974415","https://openalex.org/W2141111992","https://openalex.org/W2142577589","https://openalex.org/W2157904698","https://openalex.org/W2175591334","https://openalex.org/W2204428630","https://openalex.org/W2278613505","https://openalex.org/W2313484897","https://openalex.org/W2326826867","https://openalex.org/W2467441723","https://openalex.org/W2523101013","https://openalex.org/W2536452417","https://openalex.org/W2539358755","https://openalex.org/W2549644306","https://openalex.org/W2561881161","https://openalex.org/W2565433170","https://openalex.org/W2597520839","https://openalex.org/W7073553364"],"related_works":["https://openalex.org/W2300679492","https://openalex.org/W2908850704","https://openalex.org/W2774037113","https://openalex.org/W2801420363","https://openalex.org/W2906439237","https://openalex.org/W3004254477","https://openalex.org/W3183610383","https://openalex.org/W3093955355","https://openalex.org/W2511556388","https://openalex.org/W3154769295"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":19},{"year":2025,"cited_by_count":21},{"year":2024,"cited_by_count":24},{"year":2023,"cited_by_count":29},{"year":2022,"cited_by_count":24},{"year":2021,"cited_by_count":28},{"year":2020,"cited_by_count":22},{"year":2019,"cited_by_count":22},{"year":2018,"cited_by_count":14},{"year":2017,"cited_by_count":3}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2017-07-21T00:00:00"}